Validated UPLC-MS/MS method for determination of hordenine in rat plasma and its application to pharmacokinetic study

Journal of Pharmaceutical and Biomedical Analysis

Volumn 111, Issue , 2015, Pages 131-137

  Ma, Jianshe ^a   Wang, Shuanghu ^b   Huang, Xueli ^a   Geng, Peiwu ^b   Wen, Congcong ^a   Zhou, Yunfang ^b   Yu, Linsheng ^a   Wang, Xianqin ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b LISHUI PEOPLE S HOSPITAL   (China)

Author keywords

HILIC; Hordenine; Pharmacokinetics; Rat plasma; UPLC MS MS

Indexed keywords

ACETONITRILE; AMMONIUM FORMATE; CARBAMAZEPINE; DIAZEPAM; FORMIC ACID; HORDENINE; MIDAZOLAM; TYRAMINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; FREEZE THAWING; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LIMIT OF DETECTION; MALE; MAXIMUM PLASMA CONCENTRATION; MEASUREMENT ACCURACY; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RAT; SOLID PHASE EXTRACTION; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION; TISSUE DISTRIBUTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PLASMA; PROCEDURES; REPRODUCIBILITY;

ANIMALS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; LIMIT OF DETECTION; MALE; PLASMA; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TYRAMINE;

EID: 84928537007     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2015.03.032     Document Type: Article

References (34)

1. Frank M., Weckman T.J., Wood T., Woods W.E., Tai C.L., Chang S.L., Ewing A., Blake J.W., Tobin T. Hordenine: pharmacology, pharmacokinetics and behavioural effects in the horse. Equine Vet. J. 1990, 22:437-441.
2. Sander L.C., Putzbach K., Nelson B.C., Rimmer C.A., Bedner M., Thomas J.B., Porter B.J., Wood L.J., Schantz M.M., Murphy K.E., Sharpless K.E., Wise S.A., Yen J.H., Siitonen P.H., Evans R.L., Nguyen Pho A., Roman M.C., Betz J.M. Certification of standard reference materials containing bitter orange. Anal. Bioanal. Chem. 2008, 391:2023-2034.
3. Lovett J.V., Hoult A.H., Christen O. Biologically active secondary metabolites of barley IV. Hordenine production by different barley lines. J. Chem. Ecol. 1994, 20:1945-1954.
4. Rao G.S. Identity of peyocactin, an antibiotic from peyote (Lophophora williamsii), and hordenine. J. Pharm. Pharmacol. 1970, 22:544-545.
5. Barwell C.J., Basma A.N., Lafi M.A., Leake L.D. Deamination of hordenine by monoamine oxidase and its action on vasa deferentia of the rat. J. Pharm. Pharmacol. 1989, 41:421-423.
6. Yokoo Y., Kohda H., Kusumoto A., Naoki H., Matsumoto N., Amachi T., Suwa Y., Fukazawa H., Ishida H., Tsuji K., Nukaya H. Isolation from beer and structural determination of a potent stimulant of gastrin release. Alcohol Alcohol. 1999, 34:161-168.
7. Kim S.C., Lee J.H., Kim M.H., Lee J.A., Kim Y.B., Jung E., Kim Y.S., Lee J., Park D. Hordenine, a single compound produced during barley germination, inhibits melanogenesis in human melanocytes. Food Chem. 2013, 141:174-181.
8. Chen Y., Meng J., Zou J., An J. Selective extraction based on poly(MAA-VB-EGMDA) monolith followed by HPLC for determination of hordenine in plasma and urine samples. Biomed. Chromatogr. 2014.
9. Hoult A.H., Lovett J.V. Biologically active secondary metabolites of barley. III. A method for identification and quantification of hordenine and gramine in barley by high-performance liquid chromatography. J. Chem. Ecol. 1993, 19:2245-2254.
10. Pellati F., Benvenuti S. Chromatographic and electrophoretic methods for the analysis of phenethylamine [corrected] alkaloids in Citrus aurantium. J. Chromatogr. A 2007, 1161:71-88.
11. Pellati F., Benvenuti S. Fast high-performance liquid chromatography analysis of phenethylamine alkaloids in Citrus natural products on a pentafluorophenylpropyl stationary phase. J. Chromatogr. A 2007, 1165:58-66.
12. Viana C., Zemolin G.M., Lima F.O., de Carvalho L.M., Bottoli C.B., Limberger R.P. High-performance liquid chromatographic analysis of biogenic amines in pharmaceutical products containing Citrus aurantium. Food Addit. Contam. Part A: Chem. Anal. Control Expo. Risk Assess. 2013, 30:634-642.
13. Zhou L., Hopkins A.A., Huhman D.V., Sumner L.W. Efficient and sensitive method for quantitative analysis of alkaloids in hardinggrass (Phalaris aquatica L.). J. Agric. Food Chem. 2006, 54:9287-9291.
14. Nelson B.C., Putzbach K., Sharpless K.E., Sander L.C. Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium). J. Agric. Food Chem. 2007, 55:9769-9775.
15. Putzbach K., Rimmer C.A., Sharpless K.E., Wise S.A., Sander L.C. Determination of bitter orange alkaloids in dietary supplement standard reference materials by liquid chromatography with atmospheric-pressure ionization mass spectrometry. Anal. Bioanal. Chem. 2007, 389:197-205.
16. Nguyen D.T., Guillarme D., Heinisch S., Barrioulet M.P., Rocca J.L., Rudaz S., Veuthey J.L. High throughput liquid chromatography with sub-2 microm particles at high pressure and high temperature. J. Chromatogr. A 2007, 1167:76-84.
17. Goodwin L., White S.A., Spooner N. Evaluation of ultra-performance liquid chromatography in the bioanalysis of small molecule drug candidates in plasma. J. Chromatogr. Sci. 2007, 45:298-304.
18. Draft Guidance for Industry on Bioanalytical Method Validation 2013, U.S. Department of Health and Human Services Food and Drug Administration.
19. Guidance on Bioanalytical Method Validation 2011, EMEA/CHMP/EWP/192217/2009 Committee for Medicinal Products for Human Use (CHMP).
20. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
21. Rocci M.L., Devanarayan V., Haughey D.B., Jardieu P. Confirmatory reanalysis of incurred bioanalytical samples. AAPS J. 2007, 9:E336-E343.
22. Fast D.M., Kelley M., Viswanathan C.T., O'Shaughnessy J., King S.P., Chaudhary A., Weiner R., DeStefano A.J., Tang D. Workshop report and follow-up - AAPS Workshop on current topics in GLP bioanalysis: assay reproducibility for incurred samples - implications of Crystal City recommendations. AAPS J. 2009, 11:238-241.
23. Yadav M., Shrivastav P.S. Incurred sample reanalysis (ISR): a decisive tool in bioanalytical research. Bioanalysis 2011, 3:1007-1024.
24. Williams J.S., Donahue S.H., Gao H., Brummel C.L. Universal LC-MS method for minimized carryover in a discovery bioanalytical setting. Bioanalysis 2012, 4:1025-1037.
25. Akrami A., Hsieh F., Almon V., Bruenner B.A., James C., Wong P. Simultaneous determination of a p38 MAP kinase inhibitor and its amide hydrolyzed metabolite in Cynomolgus monkey plasma by LC-MS/MS, and its application to a toxicokinetic study. J. Pharm. Biomed. Anal. 2011, 55:1104-1110.
26. Chen L., Chen H., Shen M. Hydrophilic interaction chromatography combined with tandem mass spectrometry method for the quantification of tobramycin in human plasma and its application in a pharmacokinetic study. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2014, 973C:39-44.
27. Parker S.L., Lipman L., Roberts J.A., Wallis S.C. A simple LC-MS/MS method using HILIC chromatography for the determination of fosfomycin in plasma and urine: application to a pilot pharmacokinetic study in humans. J. Pharm. Biomed. Anal. 2015, 105:39-45.
28. Wen C., Lin C., Cai X., Ma J., Wang X. Determination of sec-O-glucosylhamaudol in rat plasma by gradient elution liquid chromatography-mass spectrometry. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2014, 944:35-38.
29. Zhang Q., Wen C., Xiang Z., Ma J., Wang X. Determination of CUDC-101 in rat plasma by liquid chromatography mass spectrometry and its application to a pharmacokinetic study. J. Pharm. Biomed. Anal. 2014, 90:134-138.
30. Wang X., Chen M., Wen C., Zhang Q., Ma J. Determination of chidamide in rat plasma by LC-MS and its application to pharmacokinetics study. Biomed. Chromatogr. 2013, 27:1801-1806.
31. Ma J., Ding X., Sun C., Lin C., An X., Lin G., Yang X., Wang X. Development and validation a liquid chromatography mass spectrometry for determination of solasodine in rat plasma and its application to a pharmacokinetic study. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2014, 963:24-28.
32. Ma J., Lin C., Wen C., Xiang Z., Yang X., Wang X. Determination of bicuculline in rat plasma by liquid chromatography mass spectrometry and its application in a pharmacokinetic study. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2014, 953-954:143-146.
33. Du J., Zhang Y., Chen Y., Liu D., Chen X., Zhong D. Enantioselective HPLC determination and pharmacokinetic study of secnidazole enantiomers in rats. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2014, 965:224-230.
34. Zhao L., Sun X., Xiong Z., Wang S. Simultaneous determination of mosapride and its active des-p-fluorobenzyl and 4'-N-oxide metabolites in rat plasma using UPLC-MS/MS: an application for a pharmacokinetic study. Talanta 2015, 137:130-135.